| Primary |
| Atrial Fibrillation |
46.1% |
| Hypertension |
16.8% |
| Deep Vein Thrombosis |
5.3% |
| Prophylaxis |
4.8% |
| Thrombosis Prophylaxis |
4.0% |
| Myocardial Ischaemia |
3.2% |
| Pulmonary Embolism |
2.1% |
| Diabetes Mellitus |
1.9% |
| Back Pain |
1.6% |
| Bronchopneumonia |
1.6% |
| Cardiac Failure |
1.6% |
| Mitral Valve Replacement |
1.6% |
| Cardiac Valve Prosthesis User |
1.3% |
| Epilepsy |
1.3% |
| Hypertensive Heart Disease |
1.3% |
| Anticoagulant Therapy |
1.1% |
| Bronchitis |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Pneumonia |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
|
| International Normalised Ratio Increased |
17.8% |
| Subdural Haematoma |
9.2% |
| Melaena |
8.6% |
| Anaemia |
5.9% |
| Hypocoagulable State |
5.9% |
| Overdose |
5.9% |
| Haematoma |
5.3% |
| Head Injury |
4.6% |
| Renal Failure Acute |
4.6% |
| Syncope |
4.6% |
| Presyncope |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Epistaxis |
3.3% |
| Vomiting |
3.3% |
| Pneumonia |
2.6% |
| Toxicity To Various Agents |
2.6% |
| Cerebral Haemorrhage |
2.0% |
| Injury |
2.0% |
| Iron Deficiency Anaemia |
2.0% |
| Pallor |
2.0% |
|
| Secondary |
| Hiv Infection |
20.0% |
| Arterial Disorder |
6.7% |
| Atrial Fibrillation |
6.7% |
| Cardiac Valve Prosthesis User |
6.7% |
| Constipation |
6.7% |
| Deep Vein Thrombosis |
6.7% |
| Embolism Venous |
6.7% |
| Hypertension |
6.7% |
| Ischaemic Stroke |
6.7% |
| Pain |
6.7% |
| Pneumonia |
6.7% |
| Pulmonary Embolism |
6.7% |
| Pyrexia |
6.7% |
|
| Pneumonia |
25.0% |
| Renal Failure Acute |
25.0% |
| Sepsis |
25.0% |
| Uterine Disorder |
25.0% |
|
| Interacting |
| Atrial Fibrillation |
15.4% |
| Depression |
15.4% |
| Hypertension |
15.4% |
| Arrhythmia Prophylaxis |
7.7% |
| Bronchitis |
7.7% |
| Bronchitis Chronic |
7.7% |
| Prophylaxis |
7.7% |
| Skin Ulcer |
7.7% |
| Thrombosis Prophylaxis |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
|
| Rectal Haemorrhage |
50.0% |
| Vertigo |
50.0% |
|
